首页> 外文会议>European Association of Cranio-Maxillo-Facial Surgery >The role of tumor markers and another clinico-laboratories results in prognosis of relapse oral squamous cell carcinoma.
【24h】

The role of tumor markers and another clinico-laboratories results in prognosis of relapse oral squamous cell carcinoma.

机译:肿瘤标志物和另一种临床实验室的作用导致复发口腔鳞状细胞癌的预后。

获取原文

摘要

The most common malignancy of the oral cavity is squamous cell carcinoma (SCC). In our population, according to epidemiological data, the most part of all (37,3%) SCC of oral mucous tissue spreads over tongue, 28,7% are the share of SCC of the tissues of the mouth floor, and the other 33% are the share of buccal and upper and lower lips. The prognosis of oral cavity carcinoma is limited by recurrent disease or lymph node metastasis. Secondary to, chemotherapy, surgery and radiotherapy, anatomical structures are often severely changed and make early diagnosis of renewed tumor growth by clinical and radiological examination difficult. The aim of this study was to estimate prognostic importance of value of serum tumor markers (CEA, SCC-Ag), performances of peripheral blood (WBC, ACN, PLT) characteristics, histological type of the tumor, tumor size in relation to the appearance of lymph node metastases and relapse in oral SCC.
机译:口腔最常见的恶性肿瘤是鳞状细胞癌(SCC)。在我们的人口中,根据流行病学数据,所有(37,3%)的口腔粘膜组织SCC的大部分都会在舌头上传播,28,7%是口地板组织的SCC的份额,另一个33 %是颊和上唇和下唇的份额。口腔癌的预后受到复发性疾病或淋巴结转移的限制。继发于,化疗,手术和放射疗法,解剖结构往往严重改变,并通过临床和放射线检查进行早期诊断临床和放射性肿瘤增长。本研究的目的是估计血清肿瘤标志物(CEA,SCC-AG)的价值的预后重要性,外周血(WBC,ACN,PLT)特征,肿瘤组织学类型,肿瘤大小与外观相关淋巴结转移和口服SCC复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号